Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit ASCO is a global professional society ...

CHARLOTTE, N.C.—Honeywell has announced the completion of its acquisition of Carrier Global Corporation's Global Access Solutions business for $4.95 billion. According to Honeywell, the deal positions ...

As AI adoption accelerates globally, questions of equity and access are coming to the forefront. Speaking with GZERO’s Tony ...

CHARLOTTE, N.C.—Honeywell announced plans to enhance and strengthen its building automation capabilities with the acquisition of Carrier Global Corporation’s Global Access Solutions business for $4.95 ...

The International Agency for Research on Cancer forecasts over 35 million new cancer cases in 2050 globally. The growing burden of cancer reflects the urgent need for global collaboration by academic ...

At the Bill & Melinda Gates Foundation, we believe that everyone deserves the chance to live a healthy and productive life. For this aspiration to become reality, all people need access to innovations ...

Initial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively ...

The Fusemachines Reseller Network represents a key strategic initiative driving scalable revenue growth and expanding market access through a robust ecosystem of regional and global collaborators. By ...

“Unfortunately, limited access to these therapies worldwide appears to be a major challenge,” the researchers wrote. A recent study featured at the 65th American Society of Hematology Annual Meeting ...

In a world where borders are tightening but opportunities are going global, a new African narrative is emerging — one built ...

Sickle cell disease (SCD) is a pressing global health issue, with rising cases and mortality, especially in low- and middle-income countries (LMICs). Hydroxyurea, a cost-effective treatment for SCD, ...